Cancer – recognition and referral

Refer people using a suspected cancer pathway referral for lung cancer if they:

Offer an urgent chest X-ray (to be done within 2 weeks) to assess for lung cancer in people aged 40 and over if they have 2 or more of the following unexplained symptoms, or if they have ever smoked and have 1 or more of the following unexplained symptoms:

Consider an urgent chest X-ray (to be done within 2 weeks) to assess for lung cancer in people aged 40 and over with any of the following:

Refer people using a suspected cancer pathway referral for mesothelioma if they have chest X-ray findings that suggest mesothelioma.

Offer an urgent chest X‑ray (to be done within 2 weeks) to assess for mesothelioma in people aged 40 and over, if:

Consider an urgent chest X‑ray (to be done within 2 weeks) to assess for mesothelioma in people aged 40 and over with either:

Offer urgent, direct access upper gastrointestinal endoscopy (to be done within 2 weeks) to assess for oesophageal cancer in people:

Consider non-urgent, direct access upper gastrointestinal endoscopy to assess for oesophageal cancer in people with haematemesis.

Consider non-urgent, direct access upper gastrointestinal endoscopy to assess for oesophageal cancer in people aged 55 or over with:

Refer people using a suspected cancer pathway referral for pancreatic cancer if they are aged 40 and over and have jaundice.

Consider an urgent, direct access CT scan (to be done within 2 weeks), or an urgent ultrasound scan if CT is not available, to assess for pancreatic cancer in people aged 60 and over with weight loss and any of the following:

Consider a suspected cancer pathway referral for people with an upper abdominal mass consistent with stomach cancer.

Offer urgent, direct access upper gastrointestinal endoscopy (to be done within 2 weeks) to assess for stomach cancer in people:

Consider non-urgent, direct access upper gastrointestinal endoscopy to assess for stomach cancer in people with haematemesis.

Consider non-urgent, direct access upper gastrointestinal endoscopy to assess for stomach cancer in people aged 55 or over with:

Consider an urgent, direct access ultrasound scan (to be done within 2 weeks) to assess for gall bladder cancer in people with an upper abdominal mass consistent with an enlarged gall bladder.

Consider an urgent, direct access ultrasound scan (to be done within 2 weeks) to assess for liver cancer in people with an upper abdominal mass consistent with an enlarged liver.

Offer quantitative faecal immunochemical testing (FIT) using HM‑JACKarc or OC‑Sensor to guide referral for suspected colorectal cancer in adults:

Refer adults using a suspected cancer pathway referral for colorectal cancer if they have a FIT result of at least 10 micrograms of haemoglobin per gram of faeces.

For people who have not returned a faecal sample or who have a FIT result below 10 micrograms of haemoglobin per gram of faeces:

Clinicians should consider if people need additional help, information or support to return their sample.

Consider a suspected cancer pathway referral for colorectal cancer in adults with a rectal mass.

Consider a suspected cancer pathway referral for anal cancer in people with an unexplained anal mass or unexplained anal ulceration.

Refer people using a suspected cancer pathway referral for breast cancer if they are:

Consider a suspected cancer pathway referral for breast cancer in people:

Consider non-urgent referral in people aged under 30 with an unexplained breast lump with or without pain. See also recommendations 1.16.2 and 1.16.3 for information about seeking specialist advice.

Make a referral to a gynaecological cancer service using a suspected cancer pathway referral if physical examination identifies ascites and/or a pelvic or abdominal mass (which is not obviously uterine fibroids).

Carry out tests in primary care (see recommendations 1.5.6 to 1.5.9) if a woman (especially if aged 50 or over) reports having any of the following symptoms on a persistent or frequent basis – particularly more than 12 times per month:

Consider carrying out tests in primary care (see recommendations 1.5.6 to 1.5.9) if a woman reports unexplained weight loss, fatigue or changes in bowel habit.

Advise any woman who is not suspected of having ovarian cancer to return to her GP if her symptoms become more frequent and/or persistent.

Carry out appropriate tests for ovarian cancer (see recommendations 1.5.6 to 1.5.9) in any woman aged 50 or over who has experienced symptoms within the last 12 months that suggest irritable bowel syndrome (IBS), because IBS rarely presents for the first time in women of this age. (See NICE's guideline on irritable bowel syndrome in adults).

Measure serum CA125 in primary care in women with symptoms that suggest ovarian cancer (see recommendations 1.5.1 to 1.5.5).

If serum CA125 is 35 IU/ml or greater, arrange an ultrasound scan of the abdomen and pelvis.

If the ultrasound suggests ovarian cancer, make a referral to a gynaecological cancer service using a suspected cancer pathway referral.

For any woman who has normal serum CA125 (less than 35 IU/ml), or CA125 of 35 IU/ml or greater but a normal ultrasound:

Refer women using a suspected cancer pathway referral for endometrial cancer if they are aged 55 and over with post‑menopausal bleeding (unexplained vaginal bleeding more than 12 months after menstruation has stopped because of the menopause).

Consider a suspected cancer pathway referral for endometrial cancer in women aged under 55 with post‑menopausal bleeding.

Consider a direct access ultrasound scan to assess for endometrial cancer in women aged 55 and over with:

Consider a suspected cancer pathway referral for women if, on examination, the appearance of their cervix is consistent with cervical cancer.

Consider a suspected cancer pathway referral for vulval cancer in women with an unexplained vulval lump, ulceration or bleeding.

Consider a suspected cancer pathway referral for vaginal cancer in women with an unexplained palpable mass in or at the entrance to the vagina.

Refer people using a suspected cancer pathway referral for prostate cancer if their prostate feels malignant on digital rectal examination.

Consider a prostate‑specific antigen (PSA) test and digital rectal examination to assess for prostate cancer in people with:

Consider referring people with possible symptoms of prostate cancer, as specified in recommendation 1.6.2, using a suspected cancer pathway referral for prostate cancer if their PSA levels are above the threshold for their age in table 1. Take into account the person's preferences and any comorbidities when making the decision.

Refer people using a suspected cancer pathway referral for bladder cancer if they are:

Consider non-urgent referral for bladder cancer in people aged 60 and over with recurrent or persistent unexplained urinary tract infection.

Refer people using a suspected cancer pathway referral for renal cancer if they are aged 45 and over and have:

Consider a suspected cancer pathway referral for testicular cancer in men if they have a non‑painful enlargement or change in shape or texture of the testis.

Consider a direct access ultrasound scan for testicular cancer in men with unexplained or persistent testicular symptoms.

Consider a suspected cancer pathway referral for penile cancer in men if they have:

Consider a suspected cancer pathway referral for penile cancer in men with unexplained or persistent symptoms affecting the foreskin or glans.

Refer people using a suspected cancer pathway referral for melanoma if they have a suspicious pigmented skin lesion with a weighted 7‑point checklist score of 3 or more.

Weighted 7‑point checklist

Major features of the lesions (scoring 2 points each):

• change in size
• irregular shape
• irregular colour.

Minor features of the lesions (scoring 1 point each):

• largest diameter 7 mm or more
• inflammation
• oozing
• change in sensation.

Refer people using a suspected cancer pathway referral if dermoscopy suggests melanoma of the skin.

Consider a suspected cancer pathway referral for melanoma in people with a pigmented or non‑pigmented skin lesion that suggests nodular melanoma.

Consider a suspected cancer pathway referral for people with a skin lesion that raises the suspicion of squamous cell carcinoma.

Consider routine referral for people if they have a skin lesion that raises the suspicion of a basal cell carcinoma. (Typical features of basal cell carcinoma include: an ulcer with a raised rolled edge; prominent fine blood vessels around a lesion; or a nodule on the skin [particularly pearly or waxy nodules].)

Only consider a suspected cancer pathway referral for people with a skin lesion that raises the suspicion of a basal cell carcinoma if there is particular concern that a delay may have a significant impact, because of factors such as lesion site or size.

Follow NICE's guidance on improving outcomes for people with skin tumours including melanoma for advice on who should excise suspected basal cell carcinomas.

Consider a suspected cancer pathway referral for laryngeal cancer in people aged 45 and over with:

Consider a suspected cancer pathway referral for oral cancer in people with either:

Consider an urgent referral (for an appointment within 2 weeks) for assessment for possible oral cancer by a dentist in people who have either:

Consider a suspected cancer pathway referral by the dentist for oral cancer in people when assessed by a dentist as having either:

Consider a suspected cancer pathway referral for thyroid cancer in people with an unexplained thyroid lump.

Consider an urgent, direct access, MRI scan of the brain (or CT scan if MRI is contraindicated; to be done within 2 weeks) to assess for brain or central nervous system cancer in adults with progressive, sub‑acute loss of central neurological function.

Consider a very urgent referral (for an appointment within 48 hours) for suspected brain or central nervous system cancer in children and young people with newly abnormal cerebellar or other central neurological function.

Consider a very urgent full blood count (within 48 hours) to assess for leukaemia in adults with any of the following:

Refer children and young people for immediate specialist assessment for leukaemia if they have unexplained petechiae or hepatosplenomegaly.

Offer a very urgent full blood count (within 48 hours) to assess for leukaemia in children and young people with any of the following:

Offer a full blood count and blood tests for calcium and plasma viscosity or erythrocyte sedimentation rate to assess for myeloma in people aged 60 and over with persistent bone pain, particularly back pain, or unexplained fracture.

Offer very urgent protein electrophoresis and a Bence–Jones protein urine test (within 48 hours) to assess for myeloma in people aged 60 and over with hypercalcaemia or leukopenia and a presentation that is consistent with possible myeloma.

Consider very urgent protein electrophoresis and a Bence–Jones protein urine test (within 48 hours) to assess for myeloma if the plasma viscosity or erythrocyte sedimentation rate and presentation are consistent with possible myeloma.

Refer people using a suspected cancer pathway referral if the results of protein electrophoresis or a Bence–Jones protein urine test suggest myeloma.

Consider a suspected cancer pathway referral for non‑Hodgkin's lymphoma in adults presenting with unexplained lymphadenopathy or splenomegaly. When considering referral, take into account any associated symptoms, particularly fever, night sweats, shortness of breath, pruritus or weight loss.

Consider a very urgent referral (for an appointment within 48 hours) for specialist assessment for non‑Hodgkin's lymphoma in children and young people presenting with unexplained lymphadenopathy or splenomegaly. When considering referral, take into account any associated symptoms, particularly fever, night sweats, shortness of breath, pruritus or weight loss.

Consider a suspected cancer pathway referral for Hodgkin's lymphoma in adults presenting with unexplained lymphadenopathy. When considering referral, take into account any associated symptoms, particularly fever, night sweats, shortness of breath, pruritus, weight loss or alcohol‑induced lymph node pain.

Consider a very urgent referral (for an appointment within 48 hours) for specialist assessment for Hodgkin's lymphoma in children and young people presenting with unexplained lymphadenopathy. When considering referral, take into account any associated symptoms, particularly fever, night sweats, shortness of breath, pruritus or weight loss.

Consider a suspected cancer pathway referral for adults if an X‑ray suggests the possibility of bone sarcoma.

Consider a very urgent referral (for an appointment within 48 hours) for specialist assessment for children and young people if an X‑ray suggests the possibility of bone sarcoma.

Consider a very urgent direct access X‑ray (to be done within 48 hours) to assess for bone sarcoma in children and young people with unexplained bone swelling or pain.

Consider an urgent, direct access ultrasound scan (to be done within 2 weeks) to assess for soft tissue sarcoma in adults with an unexplained lump that is increasing in size.

Consider a suspected cancer pathway referral for adults if they have ultrasound scan findings that are suggestive of soft tissue sarcoma or if ultrasound findings are uncertain and clinical concern persists.

Consider a very urgent, direct access ultrasound scan (to be done within 48 hours) to assess for soft tissue sarcoma in children and young people with an unexplained lump that is increasing in size.

Consider a very urgent referral (for an appointment within 48 hours) for children and young people if they have ultrasound scan findings that are suggestive of soft tissue sarcoma or if ultrasound findings are uncertain and clinical concern persists.

Consider very urgent referral (for an appointment within 48 hours) for specialist assessment for neuroblastoma in children with a palpable abdominal mass or unexplained enlarged abdominal organ.

Consider referral for ophthalmological assessment using a suspected cancer pathway referral for retinoblastoma in children with an absent fundal ('red') reflex. If there is new-onset squint that occurs together with an absent fundal ('red') reflex, see the recommendation on new-onset squint with loss of fundal 'red' reflex in NICE's guideline on suspected neurological conditions.